Una aproximación a los instrumentos económicos de las leyes del suelo del 2008 y 2015. ¿Hacia un cambio en el modelo de desarrollo en España?

Tras la aprobación del Real Decreto Legislativo 2/2008 –Ley del Suelo–, nos encontramos ante un modelo territorial y un modelo de desarrollo, que acaba con el arcaico patrón de ciudad dispersa, encontrándose, no obstante, ante las gravísimas consecuencias espaciales generadas por la denominada “burbuja inmobiliaria”, unida a una crisis de consecuencias insospechadas, en el ámbito de la denominada globalización económica, de la que nuestro país no ha logrado sustraerse con Leyes vacías de instrumentos económicos que se han transferido a las Comunidades Autónomas, nos hallamos ante una oportunidad perdida fruto de una no siempre bien calculada descentralización. De este modo, en el presente artículo nos aproximamos a la importancia que muestran los denominados “instrumentos económicos” en la normativa que recoge los pormenores relacionados con el “suelo”, en España, en la primera de nuestras Leyes, la de 1956, en la de 2008 y en el recién aprobado Texto Refundido de la Ley del Suelo y Rehabilitación Urbana –Real Decreto Legislativo 7/2015–, en el ámbito estatal. Para ello, tras definir y valorar los enfoques conceptuales relativos al “suelo” y sus tipologías, se concretan y estudian los instrumentos económicos que se recogen en la Ley del Suelo española y su relación con las nuevas formas de “hacer ciudad”.

Human iPSC derived disease model of MERTK-associated retinitis pigmentosa

Retinitis pigmentosa (RP) represents a genetically heterogeneous group of retinal dystrophies affecting mainly the rod photoreceptors and in some instances also the retinal pigment epithelium (RPE) cells of the retina. Clinical symptoms and disease progression leading to moderate to severe loss of vision are well established and despite significant progress in the identification of causative genes, the disease pathology remains unclear. Lack of this understanding has so far hindered development of effective therapies. Here we report successful generation of human induced pluripotent stem cells (iPSC) from skin fibroblasts of a patient harboring a novel Ser331Cysfs*5 mutation in the MERTK gene. The patient was diagnosed with an early onset and severe form of autosomal recessive RP (arRP). Upon differentiation of these iPSC towards RPE, patient-specific RPE cells exhibited defective phagocytosis, a characteristic phenotype of MERTK deficiency observed in human patients and animal models. Thus we have created a faithful cellular model of arRP incorporating the human genetic background which will allow us to investigate in detail the disease mechanism, explore screening of a variety of therapeutic compounds/reagents and design either combined cell and gene- based therapies or independent approaches.

Low doses of ivermectin cause sensory and locomotor disorders in dung beetles

Ivermectin is a veterinary pharmaceutical generally used to control the ecto- and endoparasites of livestock, but its use has resulted in adverse effects on coprophilous insects, causing population decline and biodiversity loss. There is currently no information regarding the direct effects of ivermectin on dung beetle physiology and behaviour. Here, based on electroantennography and spontaneous muscle force tests, we show sub-lethal disorders caused by ivermectin in sensory and locomotor systems of Scarabaeus cicatricosus, a key dung beetle species in Mediterranean ecosystems. Our findings show that ivermectin decreases the olfactory and locomotor capacity of dung beetles, preventing them from performing basic biological activities. These effects are observed at concentrations lower than those usually measured in the dung of treated livestock. Taking into account that ivermectin acts on both glutamate-gated and GABA-gated chloride ion channels of nerve and muscle cells, we predict that ivermectin’s effects at the physiological level could influence many members of the dung pat community. The results indicate that the decline of dung beetle populations could be related to the harmful effects of chemical contamination in the dung.

An updated evolutionary classification of CRISPR–Cas systems

The evolution of CRISPR–cas loci, which encode adaptive immune systems in archaea and bacteria, involves rapid changes, in particular numerous rearrangements of the locus architecture and horizontal transfer of complete loci or individual modules. These dynamics complicate straightforward phylogenetic classification, but here we present an approach combining the analysis of signature protein families and features of the architecture of cas loci that unambiguously partitions most CRISPR–cas loci into distinct classes, types and subtypes. The new classification retains the overall structure of the previous version but is expanded to now encompass two classes, five types and 16 subtypes. The relative stability of the classification suggests that the most prevalent variants of CRISPR–Cas systems are already known. However, the existence of rare, currently unclassifiable variants implies that additional types and subtypes remain to be characterized.